OrganOx
UKEntry
2022
Hold
3yr
Exit
2025
Who owns OrganOx?
OrganOx was owned by Lauxera Capital Partners through Lauxera Growth I (2022 vintage) from 2022 to 2025, exited via Trade Sale. Across its history, OrganOx has been through 4 private equity ownership periods, detailed in the timeline below.
Buyer identity available on Pro.
Hand-verified · updated 2026-04-21
Most recent investor
Lauxera Capital PartnersLauxera Growth I · 2022 · Growth
4 ownership periods · full history below
Key facts
Key takeaways
- ·Fully exited in 2025.
- ·Average hold across 4 realized cycles: 6 years.
- ·4 distinct PE sponsors across ownership cycles.
Ownership history
4 ownership periods · co-invest detected
Exited
Last exited in 2025 to .
Co-invest · 4 holders · 2011 · 2025
Amadeus Capital PartnersExited 2025
2011 · 2025(14yr) · Amadeus IV Digital Prosperity Fund · 2013 · Growth
Trade Sale · to
MOIC
–
Lauxera Capital PartnersExited 2025
2022 · 2025(3yr) · Lauxera Growth I · 2022 · Growth
Trade Sale · to
MOIC
–
More from Lauxera Growth I
Other portfolio companies in the same fund.
Sweden
France
Germany
DenmarkMore PE-backed in MedTech
Comparable medtech deals from other GPs.
USTrack OrganOx
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy OrganOx?
5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on OrganOx.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue